GH
MGNX icon

GAM Holding’s MacroGenics MGNX Stock Holding History

GAM Holding’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-22,600
Closed -$429K – 869
2017
Q4 		$429K Hold
22,600
– – 0.01% 764
2017
Q3 		$418K Hold
22,600
– – 0.02% 451
2017
Q2 		$396K Hold
22,600
– – 0.01% 848
2017
Q1 		$420K Hold
22,600
– – 0.01% 836
2016
Q4 		$462K Hold
22,600
– – 0.01% 772
2016
Q3 		$676K Sell
22,600
-55,200
-71% -$1.64M 0.01% 668
2016
Q2 		$2.1M Buy
77,800
+14,700
+23% +$331K 0.03% 506
2016
Q1 		$1.18M Hold
63,100
– – 0.02% 597
2015
Q4 		$1.95M Buy
63,100
+34,200
+118% +$1.04M 0.03% 504
2015
Q3 		$619K Buy
+28,900
New +$907K 0.01% 792

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

GAM Holding's MGNX Position: Q1 2018 in Review

GAM Holding sold out of MacroGenics (MGNX) in Q1 2018, closing a stake of 22,600 shares — an estimated $429K sold.

GAM Holding first reported a position in MGNX in Q3 2015 and held it in 10 quarters. The position peaked at $2.1M in Q2 2016. 132 funds tracked by Wall St. Rank hold MGNX as of Q1 2018.

  • GAM Holding reported no remaining MacroGenics position as of Q1 2018 after selling out during the quarter.
  • GAM Holding sold 22,600 MacroGenics shares in Q1 2018, an estimated $429K.
  • GAM Holding first reported a position in MacroGenics in Q3 2015 and held it in 10 quarters.
  • GAM Holding's MacroGenics position peaked at $2.1M in Q2 2016.
  • 132 funds tracked by Wall St. Rank held MacroGenics as of Q1 2018.

Based on GAM Holding's 13F filing for Q1 2018, filed 15 May 2018.